The TGA described the eye disorder, non-arteritic anterior ischaemic optic neuropathy (NAION), as a rare but serious condition that may result in permanent visual impairment, including blindness and no treatment has been shown to improve visual acuity outcomes
As a result, GLP-1 medications are contraindicated in patients with a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Policy, Employer Perspectives and Strategies Employers offering health benefits were asked about several aspects of their plan designs, network and coverage
Regular monitoring of cardiovascular health markers, such as blood pressure and lipid profiles, is essential to assess the effectiveness of tirzepatide and make any necessary adjustments
EEUU aprob la primera pldora oral GLP-1 contra la obesidad La compaa, que espera lanzarla en EEUU a principios de enero de 2026 , present el tratamiento en la segunda mitad de 2025 en la Agencia Europea de Medicamentos (EMA) y otras autoridades reguladoras
Its a little different," Chiang explained
